In a phase 1-2a study, 30 patients with relapsed acute lymphoblastic leukemia (ALL) received autologous T cells transduced with CD19-directed CAR (CTL019) lentiviral vector. The gene discussed is CD19; the disease is acute lymphoblastic leukemia.